|
|
Volumn 68, Issue 9, 2007, Pages 688-690
|
|
Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
TEMOZOLOMIDE;
ALKYLATING AGENT;
DACARBAZINE;
DRUG DERIVATIVE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CONTROLLED STUDY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEASIBILITY STUDY;
FEMALE;
GASTROINTESTINAL SYMPTOM;
GLIOMA;
HUMAN;
INFECTION;
LEUKOPENIA;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MALE;
MULTIPLE CYCLE TREATMENT;
PRIORITY JOURNAL;
RECURRENT DISEASE;
THROMBOCYTOPENIA;
BRAIN TUMOR;
CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
LONGITUDINAL STUDY;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
RISK ASSESSMENT;
RISK FACTOR;
SURVIVAL;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, ALKYLATING;
BRAIN NEOPLASMS;
DACARBAZINE;
DISEASE-FREE SURVIVAL;
FEASIBILITY STUDIES;
FEMALE;
GLIOMA;
HUMANS;
LONGITUDINAL STUDIES;
MALE;
MIDDLE AGED;
RISK ASSESSMENT;
RISK FACTORS;
SURVIVAL ANALYSIS;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 33947533746
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/01.wnl.0000255937.27012.ee Document Type: Article |
|
Times cited : (79)
|
|
References (9)
|
